Venous Thromboembolism - Management Disease Summary

Last updated: 03 December 2024

Content on this page:

Content on this page:

Overview

Venous thromboembolism (VTE) is most commonly manifested as pulmonary embolism (PE) and deep venous thrombosis (DVT) and is associated with significant morbidity and mortality. These diseases are defined in the Introduction section.

Incidence and prevalence of venous thromboembolism are stated in the Epidemiology section.

The mechanisms involved in the development of venous thromboembolism per Virchow’s triad theory are discussed in the Pathophysiology section.

Provoking factors for the development of venous thromboembolism may be transient/reversible or chronic/non-reversible. These as well as other risk factors are discussed in the Risk Factors section.

Classification of deep vein thrombosis according to etiology and anatomical level are identified and discussed in the Classification section. 

History and Physical Examination

Signs and symptoms that are suggestive of deep vein thrombosis and pulmonary embolism are enumerated and discussed in the Clinical Presentation section.

Diagnosis

Laboratory Tests and Ancillaries and Imaging studies to be considered in patients suspected of having deep vein thrombosis and pulmonary embolism are discussed in these sections.

Confirmation of the diagnosis of deep vein thrombosis and pulmonary embolism is essential in the management of these conditions. Pretest probability is needed to guide the diagnostic process. The Diagnosis or Diagnostic Criteria section includes the Wells Scale of Clinical Pretest Probability for both deep vein thrombosis and pulmonary embolism, the Geneva Clinical Prediction Rule for pulmonary embolism, and the pulmonary embolism rule-out criteria (PERC).

Diseases that may present similar symptoms to deep vein thrombosis and pulmonary embolism and should be ruled out are in the Differential Diagnosis section.

Management

Patients with venous thromboembolism are managed with thrombolytic therapy. In the Evaluation section, the absolute and relative contraindications to thrombolysis are enumerated. Prompt management of hemodynamically unstable patients is also discussed in this section.

In the Principles of Therapy section, phases of anticoagulation in deep vein thrombosis, general therapy principles on Heparin and anticoagulant use, and thrombolysis in pulmonary embolism are discussed in detail.

Details about the different drug options for parenteral and oral anticoagulation in the management of deep vein thrombosis and non-massive pulmonary embolism, thrombolysis of massive or sub-massive pulmonary embolism and prompt management of clinical instability are in the Pharmacological Therapy section.

Different Nonpharmacological options like bed rest and leg elevation, early ambulation, exercise and use of graduated elastic compression stockings are described. Patient education is also in this section.

In the Surgery section, different invasive procedures, thrombectomy and vena caval interruption that can be performed on patients with venous thromboembolism are discussed.

Monitoring parameters with or without anticoagulation therapy are enumerated and discussed in this section. 


Venous Thromboembolism - Disease SummaryVenous Thromboembolism - Disease Summary